Market Overview:
The global cell line development market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for bioproducts and tissue engineering & regenerative medicines, and the growing focus on drug discovery and toxicity testing. The cell line development market is segmented by type into incubators, centrifuges, bioreactors, storage equipment, automated systems, microscopes, filtration systems, and others. The incubators segment is expected to grow at the highest CAGR during the forecast period owing to the increasing demand for single-use technology in cell culture applications. On the basis of application, the cell line development market is divided into bioproduction; tissue engineering & regenerative medicines; toxicity testing; research; and drug discovery.
Product Definition:
Cell line development is the process of culturing cells in vitro for use in biotechnology and pharmacology. Cell lines are important because they allow for the mass production of proteins, including therapeutic antibodies.
Incubators:
Incubators are devices used to maintain a culture of cells at specific temperature and humidity levels. Incubators can be classified into two types, conventional and controlled environment incubators. Controlled environment incubator is further segmented into thermo-regulated (TC) and forced air/heating systems. TC incubator maintains the temperature of the cell culture by controlling the heat provided while forced air/ heating system uses warm air generated inside the chamber itself to maintain temperature control over cell cultures.
Centrifuges:
A centrifuge is a device used to separate particles of different sizes. The most common application of centrifuges is in the field of biotechnology where they are used for spinning down bacterial cells to achieve high concentration and purity. Centrifuges are also widely used in the pharmaceutical industry for purification and concentrating proteins, nucleic acids, enzymes, among others.
Application Insights:
Research application dominated the global market in 2017, accounting for over 60% of the revenue share. The growing importance of advanced cell line development platforms to support R&D activities in biopharmaceutical companies is expected to remain a key driving factor for this segment. Moreover, increasing government funding and initiatives to enhance R&R capabilities across the globe are further anticipated to propel growth during the forecast period.
Cell production application is projected register a significant CAGR from 2018 to 2030 owingto its wide-spread adoption by various industries including pharmaceuticals, food & beverage and biotechnology. Growing demand for stem cells derived from induced pluripotent stem cells (iPSCs) using automated systems has been one of the major factors contributing towards segment growth during recent years.
Tissue engineering & regenerative medicines application is anticipatedto witness substantial gains during future years due largely on advancements made in gene therapy techniques that have enabled scientists generate patient-specific tissues.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biotechnology companies, which are engaged in cell line development for research and drug discovery applications. Moreover, increasing investments by these companies for R&D activities is expected to drive regional growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising incidences of cancer and other chronic diseases due to unhealthy lifestyles coupled with genetic mutations caused due to radiation exposure or environmental pollutants. In addition, government initiatives encouraging academic institutions and research organizations from developing economies such as India & China are expected boost regional demand during the same period (2018-2030).
Growth Factors:
- Increasing demand for biologics and biosimilars
- Growing prevalence of chronic diseases
- Rising number of clinical trials and R&D investments
- Technological advancements in cell line development platforms
- Emergence of novel cell lines
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Line Development Market Research Report
By Type
Incubators, Centrifuges, Bioreactors, Storage Equipment, Automated Systems, Microscopes, Filtration Systems, Others
By Application
Bioproduction, Tissue Engineering & Regenerative Medicines, Toxicity Testing, Research, Drug Discovery
By Companies
Corning, GE Healthcare, Lonza, Sartorius, Selexis, Sigma-Aldrich, Thermo Fisher Scientific, Wuxi Apptec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Cell Line Development Market Report Segments:
The global Cell Line Development market is segmented on the basis of:
Types
Incubators, Centrifuges, Bioreactors, Storage Equipment, Automated Systems, Microscopes, Filtration Systems, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bioproduction, Tissue Engineering & Regenerative Medicines, Toxicity Testing, Research, Drug Discovery
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Corning
- GE Healthcare
- Lonza
- Sartorius
- Selexis
- Sigma-Aldrich
- Thermo Fisher Scientific
- Wuxi Apptec
Highlights of The Cell Line Development Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Incubators
- Centrifuges
- Bioreactors
- Storage Equipment
- Automated Systems
- Microscopes
- Filtration Systems
- Others
- By Application:
- Bioproduction
- Tissue Engineering & Regenerative Medicines
- Toxicity Testing
- Research
- Drug Discovery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Line Development Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell line development is the process of creating new cell lines from a sample of cells. Cell lines can be used to study specific diseases or conditions, and may also be used for drug testing.
Some of the key players operating in the cell line development market are Corning, GE Healthcare, Lonza, Sartorius, Selexis, Sigma-Aldrich, Thermo Fisher Scientific, Wuxi Apptec.
The cell line development market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Line Development Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Line Development Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Line Development Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Line Development Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Line Development Market Size & Forecast, 2020-2028
4.5.1 Cell Line Development Market Size and Y-o-Y Growth
4.5.2 Cell Line Development Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Incubators
5.2.2 Centrifuges
5.2.3 Bioreactors
5.2.4 Storage Equipment
5.2.5 Automated Systems
5.2.6 Microscopes
5.2.7 Filtration Systems
5.2.8 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Bioproduction
6.2.2 Tissue Engineering & Regenerative Medicines
6.2.3 Toxicity Testing
6.2.4 Research
6.2.5 Drug Discovery
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Line Development Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Line Development Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Incubators
9.6.2 Centrifuges
9.6.3 Bioreactors
9.6.4 Storage Equipment
9.6.5 Automated Systems
9.6.6 Microscopes
9.6.7 Filtration Systems
9.6.8 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Bioproduction
9.10.2 Tissue Engineering & Regenerative Medicines
9.10.3 Toxicity Testing
9.10.4 Research
9.10.5 Drug Discovery
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Incubators
10.6.2 Centrifuges
10.6.3 Bioreactors
10.6.4 Storage Equipment
10.6.5 Automated Systems
10.6.6 Microscopes
10.6.7 Filtration Systems
10.6.8 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Bioproduction
10.10.2 Tissue Engineering & Regenerative Medicines
10.10.3 Toxicity Testing
10.10.4 Research
10.10.5 Drug Discovery
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Incubators
11.6.2 Centrifuges
11.6.3 Bioreactors
11.6.4 Storage Equipment
11.6.5 Automated Systems
11.6.6 Microscopes
11.6.7 Filtration Systems
11.6.8 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Bioproduction
11.10.2 Tissue Engineering & Regenerative Medicines
11.10.3 Toxicity Testing
11.10.4 Research
11.10.5 Drug Discovery
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Incubators
12.6.2 Centrifuges
12.6.3 Bioreactors
12.6.4 Storage Equipment
12.6.5 Automated Systems
12.6.6 Microscopes
12.6.7 Filtration Systems
12.6.8 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Bioproduction
12.10.2 Tissue Engineering & Regenerative Medicines
12.10.3 Toxicity Testing
12.10.4 Research
12.10.5 Drug Discovery
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Incubators
13.6.2 Centrifuges
13.6.3 Bioreactors
13.6.4 Storage Equipment
13.6.5 Automated Systems
13.6.6 Microscopes
13.6.7 Filtration Systems
13.6.8 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Bioproduction
13.10.2 Tissue Engineering & Regenerative Medicines
13.10.3 Toxicity Testing
13.10.4 Research
13.10.5 Drug Discovery
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Line Development Market: Competitive Dashboard
14.2 Global Cell Line Development Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Corning
14.3.2 GE Healthcare
14.3.3 Lonza
14.3.4 Sartorius
14.3.5 Selexis
14.3.6 Sigma-Aldrich
14.3.7 Thermo Fisher Scientific
14.3.8 Wuxi Apptec
